George K. Ng - 27 Jan 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Executive Officer, Director
Signature
/s/ George Ng, by Neda A. Sharifi, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
27 Jan 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
18 Feb 2025, 17:53:15 UTC
Date Of Original Report
29 Jan 2025
Previous filing
06 Jan 2025
Next filing
18 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PCSA Common Stock 87,200 27 Jan 2025 George Ng IRRA FBO: George Ng
holding PCSA Common Stock 20,000 27 Jan 2025 Ng Cha Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Warrants Award $0 +87,200 $0.000000 87,200 29 Jan 2025 Common Stock 87,200 $0.6500 George Ng IRRA FBO: George Ng
transaction PCSA Warrants Award $0 +43,600 $0.000000 43,600 29 Jan 2025 Common Stock 43,600 $0.6500 George Ng IRRA FBO: George Ng
* An asterisk sign (*) next to the price indicates that the price is likely invalid.